关于细胞水平辐射诱导的适应反应及其在癌症治疗中的影响的见解
Aishwarya Thathamangalam Ananthanarayanan1, Venkateswarlu Raavi2, Satish Srinivas Kondaveeti3
1Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai, India.
Cytogenetic and genome research
|October 31, 2023
概括
辐射诱导适应反应 (RIAR) 解释了低剂量辐射暴露如何导致对更高剂量的耐药性. 了解RIAR机制对于优化放射治疗和预测治疗结果至关重要.
科学领域:
- 辐射生物学 辐射生物学
- 细胞放射生物学的细胞放射生物学
- 癌症治疗治疗 癌症治疗
背景情况:
- 辐射诱导适应反应 (RIAR) 描述了在初始低剂量暴露后对较高辐射剂量获得的耐药性.
- 在细胞系,动物模型和暴露在高自然背景辐射下的人群中研究了RIAR.
研究的目的:
- 审查在细胞水平上对RIAR的现有知识,特别是在低剂量启动后.
- 讨论RIAR在临床放射治疗中的影响,重点关注其在抗辐射发展中的作用.
主要方法:
- 关于辐射诱导的适应反应现有文献的综述.
- 对参与RIAR的细胞机制,信号通路和分子点的分析.
- 讨论临床相关性和可能转化为放射治疗.
主要成果:
- 低剂量辐射暴露 (<500 mGy) 可以诱导适应性反应,从而对随后的更高剂量 (Gy) 产生抗性.
- 已经阐明了调解RIAR的分子机制和信号通路,为缓解提供了目标.
- RIAR是放射电阻的发展的一个重要因素,影响了放射治疗的疗效.
结论:
- 了解RIAR对于预测和潜在地克服放射治疗中的治疗耐药性至关重要.
- 正在制定减轻RIAR介导辐射阻力的策略,包括使用特定的抑制剂.
- 瘤样本和液体活检中的生物标志物监测被提议用于临床翻译RIAR研究.
相关概念视频
Mutations
38.0K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
38.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


